Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3Venous Thromboembolism 2Urinary Bladder Neoplasms 1Sarcoma 1Rectal Diseases 1Prostatic Neoplasms 1Polycythemia Vera 1Ovarian Neoplasms 1Neoplasms by Site 1Myeloproliferative Disorders 1Intestinal Neoplasms 1Intestinal Diseases 1Hematuria 1Hematoma 1Gastrointestinal Neoplasms 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Endometrial Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Colonic Diseases 1Bone Neoplasms 1Barrett Esophagus 1

Interventions

Rocuronium 2Ofloxacin 2Mitomycin 25-aminolevulinic acid hexyl ester 2remimazolam 1penpulimab 1pembrolizumab 1mebeverine 1lornoxicam 1enfortumab vedotin 1disitamab vedotin 1Ultrasonography 1Trimethoprim, Sulfamethoxazole Drug Combination 1Tobacco Use Cessation Devices 1Tamsulosin 1Sugammadex 1Specimen Handling 1Psychiatric Rehabilitation 1Propofol 1Polymerase Chain Reaction 1Nitrofurantoin 1Neuromuscular Blockade 1Neuroleptanalgesia 1Nephroureterectomy 1Neostigmine 1Midazolam 1Metformin 1Mepivacaine 1Magnetic Resonance Spectroscopy 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Urinary Bladder Neoplasms × Aspirin × Clear all
NCT02350543 2019-04-08

Peri-operative Aspirin Continuation Versus Discontinuation

Rabin Medical Center

Phase 4 Terminated
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria

Data powered by HemOnc (CC BY 4.0) Colophon âš¡